The Genome Editing Shared Resource of Rutgers-CINJ is a state-of-the-art university core facility that offers services related to the creation of mouse and cell line models for the Rutgers research community. GESR utilizes the latest in genome editing technologies and can also work with you on special projects to study embryonic development, in vivo gene editing/therapy models and gene expression using CRISPR-based activators/repressors.
Under the leadership of senior vice president for research, Michael E. Zwick, PhD, the Office for Research is committed to assisting all researchers with the advanced tools and expertise they need, serving as a unifying force multiplier for the research community.
Rutgers startup Zena Therapeutics strives to create narcotic medications that will minimize or even eliminate overdoses from prescription drugs.
Key findings in the report highlight the persistence of disparities in tobacco use by race and ethnicity, level of income, level of education, gender identity, type of occupation, geography, and behavioral health status.